Disease management is now a $750 million industry that serves approximately 2 million Americans suffering from conditions such as cancer, heart disease, diabetes, and osteoporosis, according to US News.  In an effort to increase compliance, pharmaceutical companies are getting involved, too: their customer-focused programs educate patients about their conditions and provide tools for health management. 

Patient compliance challenges the pharmaceutical industry, which seeks ways to build lasting relationships with consumers.  According to a recent study by Cutting Edge Information, the diversity and success of disease management programs will affect consumers’ perceptions of pharmaceutical giants – who often suffer from negative publicity.  Effective, long-term programs will encourage patients to view these firms as healthcare partners rather than just drug manufacturers. 

“Constant communication free of marketing language is the most important aspect of a disease management program,” said Cutting Edge Information senior analyst Eric Bolesh.  “Many companies have launched magazines, cholesterol monitoring services, caloric intake calculators, e-zines, and other health-related services to regularly provide health information to customers.” Through its website, for example, Eli Lilly helps diabetes patients keep self-care diaries and track day-to-day symptoms and health problems.  Other companies offer similar tools for conditions ranging from arthritis to allergies to erectile dysfunction. 

“Pharmaceutical Patient Compliance and Disease Management” is Cutting Edge Information’s comprehensive study detailing compliance and disease management initiatives from leading pharmaceutical companies.  Some profiled companies include Merck, Pfizer, Novartis, Eli Lilly, and Wyeth.  The report also showcases metrics and practices in the following areas:

• Costs of patient non-compliance

• Building customer outreach through focus campaigns and data management
• Customer management spending
• Creating lifetime value

To download a summary of the 83-page report, “Pharmaceutical Patient Compliance and Disease Management” visit http://www.PharmaDiseaseManagement.com .  For more information or to learn about other research being conducted by Cutting Edge Information, contact Diana Borja at diana_borja@cuttingedgeinfo.com or 919-433-0219.

 
<-- Back to the News Page

<-- Back to the Cutting Edge Information home page